Cargando...
Homeodomain-interacting protein kinase 2 (HIPK2): a promising target for anti-cancer therapies
The HIPK2 (serine/threonine homeodomain-interacting protein kinase 2) is a “caretaker” gene, its inactivation increases tumorigenicity while its activation inhibits tumor growth. This report reviews the anti-tumorigenic mechanisms of HIPK2, which include promotion of apoptosis, inhibition of angioge...
Gardado en:
| Publicado en: | Oncotarget |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Impact Journals LLC
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386776/ https://ncbi.nlm.nih.gov/pubmed/28107201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14723 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|